Becton Dickinson and Co (BDX)

BDX on New York Consolidated

139.81USD
19 Dec 2014
Price Change (% chg)

$-0.62 (-0.44%)
Prev Close
$140.43
Open
$141.18
Day's High
$141.44
Day's Low
$139.49
Volume
1,545,345
Avg. Vol
1,605,044
52-wk High
$142.56
52-wk Low
$105.21

BDX

Chart for BDX

About

Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company's operations consist... (more)

Overall

Beta: 0.88
Market Cap (Mil.): $28,453.29
Shares Outstanding (Mil.): 204.20
Dividend: 0.60
Yield (%): 1.72

Financials

  BDX Industry Sector
P/E (TTM): 23.22 35.58 38.84
EPS (TTM): 6.00 -- --
ROI: 11.71 10.83 18.26
ROE: 23.47 12.64 19.12
Search Stocks

CORRECTED-Busy December sets up 2015

NEW YORK, Dec 5 (IFR) - Medical equipment supplier Becton Dickinson pushed the first week of December into record territory on Thursday, with a US$6.2bn five-part transaction to help pay for its US$12.2bn acquisition of CareFusion.

05 Dec 2014

Britain begins review to speed access to new drugs

* Innovative Medicines and MedTech Review to report in 2015

20 Nov 2014

U.S. judge orders Becton Dickinson to correct false syringe claims

- A U.S. federal court has ordered medical device maker Becton Dickinson and Co to notify customers that it falsely claimed its safety syringes were sharper and wasted less medicine than those of rival Retractable Technologies Inc.

11 Nov 2014

U.S. judge orders Becton Dickinson to correct false syringe claims

Nov 11 - A U.S. federal court has ordered medical device maker Becton Dickinson and Co to notify customers that it falsely claimed its safety syringes were sharper and wasted less medicine than those of rival Retractable Technologies Inc.

11 Nov 2014

Diabetes care, drug-delivery power Becton Dickinson's beat

- Medical equipment maker Becton Dickinson & Co reported better-than-expected profit and revenue, helped by strong sales in its diabetes care and drug-delivery businesses.

04 Nov 2014

UPDATE 1-Diabetes care, drug-delivery power Becton Dickinson's beat

Nov 4 - Medical equipment maker Becton Dickinson & Co reported better-than-expected profit and revenue, helped by strong sales in its diabetes care and drug-delivery businesses.

04 Nov 2014

Medical equipment supplier Becton Dickinson revenue rises

Nov 4 - Medical equipment supplier Becton Dickinson & Co reported a 4.8 percent rise in quarterly revenue due to improving demand for its drug-delivery products.

04 Nov 2014

ConvaTec owners appoint banks to explore sale: sources

LONDON - ConvaTec's owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.

15 Oct 2014

ConvaTec owners appoint banks to explore sale - sources

LONDON, Oct 15 - ConvaTec's owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.

15 Oct 2014

Goldman leads $9.1 billion bridge loan for Becton Dickinson

NEW YORK - Medical equipment supplier Becton Dickinson & Co's acquisition of medical device manufacturer CareFusion will be financed with a $9.1 billion bridge loan, bankers said on Tuesday.

07 Oct 2014

Competitors

Earnings vs. Estimates

Search Stocks